The situation experienced with COVID-19 where medical care has been overwhelmed and there is a difficulty to perform rapid and massive tests in an agile way in the population is the starting point of the project developed by CREB UPC (Research Centre for Biomedical Engineering of the Technical University of Catalonia) and funded by the Center for Development Cooperation UPC. The solution seeks to provide a low-cost tool that helps to reduce the burden on the healthcare system and act quickly in case COVID-19 symptoms are detected.
This new program will focus on supporting those startups that through technology try to introduce healthy living habits and improve the people's quality of life. The research born at CREB UPC and the "Fundació Institut de Recerca Hospital de Sant Pau", supported by "The Collider" of Mobile World Capital Barcelona has matured and is offered through the first genetic report that analyzes the activation of the 22000 genes in our body.
Health xCode is a spin-off of the IIB Sant Pau (CERCA Center - Fundació Institut de Recerca Hospital de Sant Pau) and the CREB UPC (Research Center for Biomedical Engineering) born from the research developed by Jose Manuel Soria, Alexandre Perera LLuna and Emma Roca.
Exheus analyzes gene expression with special attention to target genes, such as those integrated into metabolic pathways, inflammatory processes and infections, the immune system and other markers that control muscle damage suffered in sports training and competitions.
European Research Council is a true success story. Thanks for supporting our groundbreaking research on biomaterials, plasmas and cancer. At ERCApache, team leaded by Cristina Canal, we are working hard to produce excellent science and bring back the investment to society for a better healthcare.
Exheus, the spin-off of the “’Institut de Recerca de l’Hospital de la Sant Creu i Sant Pau – IIB Sant Pau” and CREB UPC that analyzes gene expression using artificial intelligence, has received a grant worth € 75,000 within the framework of ACCIÓ's 'Startup Capital' line of aid.
One of Exheus’ primary goals is to reduce the high-performance sports injuries and improve the associated recovery. Validated in different sports, its technology is being developed and tested with some of the main European clubs and sports centers.
